MX379883B - Composiciones para el tratamiento de infecciones producidas por el acaro demodex spp. - Google Patents

Composiciones para el tratamiento de infecciones producidas por el acaro demodex spp.

Info

Publication number
MX379883B
MX379883B MX2017008787A MX2017008787A MX379883B MX 379883 B MX379883 B MX 379883B MX 2017008787 A MX2017008787 A MX 2017008787A MX 2017008787 A MX2017008787 A MX 2017008787A MX 379883 B MX379883 B MX 379883B
Authority
MX
Mexico
Prior art keywords
compositions
mite
treatment
infections caused
oil
Prior art date
Application number
MX2017008787A
Other languages
English (en)
Other versions
MX2017008787A (es
Inventor
Meza Dary Luz Mendoza
Bermejo Eduardo Egea
De Egea Gloria Garavito
Sales Luis Carlos Escaff
Jaraba Luis Escaff
Carreño Martha Lizarazo
Llanos Raimundo Abello
Original Assignee
Procaps S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procaps S A filed Critical Procaps S A
Publication of MX2017008787A publication Critical patent/MX2017008787A/es
Publication of MX379883B publication Critical patent/MX379883B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9062—Alpinia, e.g. red ginger or galangal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a composiciones para el tratamiento de infecciones producidas por el ácaro Demodex spp que comprenden aceites esenciales seleccionado del grupo que consiste en aceite de Eruca sativa, aceite de Zingiber officinale y aceite de Alpinia officinarum incorporados en solventes y vehículos, que se presentan en un kit en forma de solución, suspensión, emulsión o dispersión. Se aplican de forma tópica para el tratamiento de infecciones y afecciones en humanos ocasionas por Demodex spp.
MX2017008787A 2014-12-30 2014-12-30 Composiciones para el tratamiento de infecciones producidas por el acaro demodex spp. MX379883B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2014/067414 WO2016108070A1 (es) 2014-12-30 2014-12-30 Composiciones para el tratamiento de infecciones producidas por el acaro demodex spp

Publications (2)

Publication Number Publication Date
MX2017008787A MX2017008787A (es) 2018-03-15
MX379883B true MX379883B (es) 2025-03-11

Family

ID=56284351

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017008787A MX379883B (es) 2014-12-30 2014-12-30 Composiciones para el tratamiento de infecciones producidas por el acaro demodex spp.

Country Status (7)

Country Link
US (1) US10357526B2 (es)
EP (1) EP3251682B1 (es)
JP (1) JP6553206B2 (es)
BR (1) BR112017014379B1 (es)
CR (1) CR20170346A (es)
MX (1) MX379883B (es)
WO (1) WO2016108070A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019142943A (ja) * 2019-04-26 2019-08-29 プロキャプス ソシエダ アノニマ ニキビダニ属種（ｄｅｍｏｄｅｘ ｓｐｐ）のダニによって引き起こされる感染症を、治療するための組成物（ｃｏｍｐｏｓｉｔｉｏｎｓ ｆｏｒ ｔｈｅ ｔｒｅａｔｍｅｎｔ ｏｆ ｉｎｆｅｃｔｉｏｎｓ ｃａｕｓｅｄ ｂｙ ｍｉｔｅ ｄｅｍｏｄｅｘ ｓｐｐ）
SE544843C2 (en) * 2019-12-23 2022-12-13 Oriflame Cosmetics Ag Plant extracts for treatment of rosacea
US20220323472A1 (en) * 2021-03-30 2022-10-13 Frank Anthony SPALLITTA Anti-parasitic compounds for the treatment and prevention of viral diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003252774A (ja) * 2002-02-26 2003-09-10 Kenji Hirano デモデクスの殺生用薬剤、化粧剤および殺生方法
US20050058672A1 (en) * 2003-09-14 2005-03-17 Bioderm Research Baby Care Skin Protectant Compositions for Diaper Rash
US7320797B2 (en) * 2003-08-29 2008-01-22 Bioderm Research Antiaging cosmetic delivery systems
US20050215635A1 (en) * 2004-03-08 2005-09-29 Rafi M Mohamed Diarylheptanoid compounds and uses thereof
WO2006119174A1 (en) * 2005-04-30 2006-11-09 Ocular Surface Center, P.A. Method for treating ocular demodex
KR100668878B1 (ko) * 2005-07-29 2007-01-12 강민용 발모제 조성물, 발모용 피부 외용제 조성물 및 발모제조성물, 발모용 피부 외용제 조성물의 제조방법
US8895080B2 (en) * 2008-06-20 2014-11-25 Ocusoft, Inc. Compositions and kits for ocular treatment
WO2012092320A2 (en) * 2010-12-29 2012-07-05 Nichamin Louis D Eye treatment
PL223972B1 (pl) * 2013-04-11 2016-11-30 Ofta Spółka Z Ograniczoną Odpowiedzialnością Olejek szałwiowy do zastosowania w leczeniu i profilaktyce stanów zapalnych wywołanych przez nużeńce, zwłaszcza zapalenia brzegów powiek oraz kompozycja farmaceutyczna zawierająca olejek szałwiowy do zastosowania w leczeniu i profilaktyce stanów zapalnych wywołanych przez nużeńce, zwłaszcza zapalenia brzegów powiek

Also Published As

Publication number Publication date
JP6553206B2 (ja) 2019-07-31
EP3251682A4 (en) 2018-12-12
WO2016108070A1 (es) 2016-07-07
CR20170346A (es) 2017-11-07
US10357526B2 (en) 2019-07-23
MX2017008787A (es) 2018-03-15
BR112017014379B1 (pt) 2021-03-02
EP3251682A1 (en) 2017-12-06
EP3251682B1 (en) 2024-02-21
BR112017014379A2 (pt) 2018-03-20
US20180353560A1 (en) 2018-12-13
JP2018501318A (ja) 2018-01-18

Similar Documents

Publication Publication Date Title
CL2017003142A1 (es) Composiciones que comprenden cepas bacterianas
CL2018001349A1 (es) Composiciones que comprenden cepas bacterianas
CL2018001367A1 (es) Composiciones que comprenden cepas bacterianas
CY1122184T1 (el) Συνθεσεις περιλαμβανουσες βακτηριακα στελεχη
BR112017009648A2 (pt) composto, métodos para tratamento de doenças alérgicas ou outras condições inflamatórias ou prevenção de doença, de rinite alérgica ou asma, composição, e, uso de um composto.
ECSP19003773A (es) Compuestos heterocíclicos como inmunomoduladores
CO2017013446A2 (es) Composiciones que comprenden cepas bacterianas del género bacteroides
UY37134A (es) Compuestos heteroarilos y composiciones que los contienen útiles como inhibidores de pad4
CL2016002877A1 (es) Compuestos de 2-cloro-2-difluorometoxifenil pirazolopirimidina, composiciones y métodos de uso de los mismos.
CL2018001368A1 (es) Composiciones que comprenden cepas bacterianas
CO2018010459A2 (es) Composiciones que comprenden cepas bacterianas
MX2022009148A (es) Composiciones y metodos para el tratamiento de hemoglobinopatias.
CR20160418A (es) Nuevos compuestos biciclicos de 7 eslabones
UY37018A (es) Inhibidores bicíclicos de pad4
CO2017013443A2 (es) Composiciones que comprenden cepas bacterianas del género blautia
MX383124B (es) Compuestos tricíclicos fusionados de piridazinona útiles para tratar infecciones de orthomyxovirus.
PE20180266A1 (es) Composiciones que comprenden cepas bacterianas
MX2018003491A (es) Represores de htt y usos de estos.
CL2016002509A1 (es) Composiciones para modular la expresión de sod-1
CL2015002529A1 (es) Compuestos de tetrahidropirrolotiazina
JOP20200157A1 (ar) أجسام مضادة ذات سلسلة ثقيلة ترتبط بـ cd22
CL2019002251A1 (es) Anticuerpos contra triptasa, composiciones de estos y usos de estos.
CL2017002482A1 (es) Compuestos heterocíclicos y su uso en la prevención o tratamiento de las infecciones bacterianas
CL2017001923A1 (es) Derivados de 9h-pirrolo-dipiridina
MX2015014181A (es) 2-acetilnafto [2,3-b]furano -4,9-diona para uso en el tratamiento del cáncer.